Ultrafiltration for the Treatment of Acute Heart Failure.

Ultrafiltration (UF) mechanically removes excess fluid volume through an extracorporeal circuit and has been applied to clinical situations in which volume removal is the mainstay of therapy. Because of this ability, UF serves as an enticing method to treat acute heart failure (AHF) in which most symptoms are driven by congestion due to excess volume. Additional physiologic properties of UF and the biochemical composition of the extracted fluid confer additional theoretic benefits in the treatment of AHF. Herein the concepts underlying UF, clinical evidence evaluating its efficacy, and ongoing challenges understanding the role of UF are reviewed.

• Publication year

  2018

• Venue

  Heart Failure Clinics

• Publication date

  2018-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.hfc.2018.06.013PMID 30266360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury

  2018cited by this paper
• Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per‐protocol analysis of CARRESS‐HF

  2018cited by this paper
• Better late than never: the true results of CARRESS‐HF

  2018cited by this paper
• Biomarkers in Cardiorenal Syndromes

  2018cited by this paper
• Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies

  2018cited by this paper
• Current drug therapy for heart failure with reduced ejection fraction

  2018cited by this paper
• Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure

  2017cited by this paper
• Diuretic Treatment in Heart Failure.

  2017cited by this paper
• Getting to the Heart of the Matter: Review of Treatment of Cardiorenal Syndrome.

  2017cited by this paper
• European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions

  2016cited by this paper
• Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure.

  2016cited by this paper
• When Business and Science Clash, How Can We Avoid Harming Patients?: The Case of AVOID-HF.

  2016cited by this paper
• Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.

  2015cited by this paper
• Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providers.

  2014cited by this paper
• Continuous ultrafiltration for congestive heart failure: the CUORE trial.

  2014cited by this paper
• The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

  2014cited by this paper
• Continuous ultrafiltration for congestive heart failure: the CUORE trial.

  2014cited by this paper
• Fluid management: the challenge of defining standards of care.

  2014cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Heart Rate Response to Fear Conditioning and Virtual Reality in Subthreshold PTSD

  2013cited by this paper
• Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

  2012cited by this paper
• Stockholm syndrome manifestation of Munchausen: an eye-catching misnomer.

  2012cited by this paper
• Clinical Trial: Methods and Design Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Rationale and Design of CARRESS-HF, for the Heart Failure Clinical Research Network

  2012cited by this paper
• Diuretic strategies in patients with acute decompensated heart failure.

  2011cited by this paper
• Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure.

  2010cited by this paper
• The Artificial Kidney: a dialyser with a great area

  2009cited by this paper
• Ultrafiltration for cardiorenal syndrome.

  2008cited by this paper
• Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

  2007cited by this paper
• Repeated hospitalizations predict mortality in the community population with heart failure.

  2007cited by this paper
• Cardiorenal versus renocardiac syndrome: is there a difference?

  2007cited by this paper
• Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

  2007cited by this paper
• Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate.

  2006cited by this paper
• Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.

  2005cited by this paper
• Reassessing treatment of acute heart failure syndromes: the ADHERE Registry

  2005cited by this paper
• Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.

  2005cited by this paper
• Prevention of heart failure: effective strategies to combat the growing epidemic.

  2003cited by this paper
• Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients.

  2003cited by this paper
• Diuretic Therapy and Resistance in Congestive Heart Failure

  2002cited by this paper
• Clinical Benefit and Approach of Ultrafiltration in Acute Heart Failure

  2001cited by this paper
• Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.

  2001cited by this paper
• Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration.

  1993cited by this paper
• Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

  1985cited by this paper
• The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report.

  1960cited by this paper

• Management of Hyponatremia in Heart Failure: Practical Considerations

  2023cites this paper
• Effectiveness of coenzyme Q10 nanoliposomes in the treatment of heart failure

  2022cites this paper
• Effect of Hypertonic Saline Solution Combined with Furosemide on Acute Heart Failure: A Meta-Analysis

  2022cites this paper
• Ultrafiltration in acute heart failure: Current knowledge and fields for further research.

  2021cites this paper
• Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment

  2021cites this paper